Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities
In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief
Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990
Policy Of 5,000 Grants Meant As Floor, Not Ceiling, Former White House Advisor Insists
“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts
DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
